IL33 and hepatocellular carcinoma: Interestingly, serum IL-33 levels were higher in HBV+ versus HBV- patients with other liver diseases, including HCC, cirrhosis, hepatic cyst, fatty liver, and liver hemangioma (Supplementary Fig. 7d).